medmix Wins One of the Largest New Beauty Businesses in Company History and Strengthens Position in Key Global Beauty Markets with Facility Extensions
medmix (MDMXF) announced two facility expansions to strengthen its Beauty segment: a new 4,000 m² production site for subsidiary Guangdong Qiaoyi in China and a major expansion of GEKA do Brasil in Cotia, Sāo Paulo.
The Qiaoyi plant adds a dedicated injection workshop, AI automation and a 3D warehouse to scale cosmetic packaging output for Asia. The GEKA expansion more than doubled the Brazilian site, insourced warehousing and increased capacity by 25%. medmix said GEKA secured one of its largest single projects, expected to deliver significant revenues in 2026–2027. Both projects emphasize automation and sustainable production.
medmix (MDMXF) ha annunciato due ampliamenti di impianti per rafforzare il suo segmento Beauty: un nuovo sito di produzione di 4.000 m² per la controllata Guangdong Qiaoyi in Cina e una significativa espansione di GEKA do Brasil a Cotia, São Paulo.
Lo stabilimento Qiaoyi aggiunge un officina di stampaggio dedicata, automazione AI e un magazzino 3D per aumentare la capacità di imballaggio cosmetico per l’Asia. L'espansione di GEKA raddoppia di gran lunga la sede brasiliana, insourcing del magazzinaggio e aumento della capacità del 25%. medmix ha affermato che GEKA ha assicurato uno dei suoi più grandi progetti singoli, che dovrebbe generare entrate significative nel 2026-2027. Entrambi i progetti pongono l'accento sull'automazione e sulla produzione sostenibile.
medmix (MDMXF) anunció dos ampliaciones de instalaciones para fortalecer su segmento de Belleza: un nuevo sitio de producción de 4,000 m² para la filial Guangdong Qiaoyi en China y una importante ampliación de GEKA do Brasil en Cotia, São Paulo.
La planta de Qiaoyi añade un taller de inyección dedicado, automatización con IA y un almacén 3D para ampliar la producción de envases cosméticos para Asia. La expansión de GEKA más que duplicó el sitio brasileño, externalizó el almacenamiento y aumentó la capacidad en un 25%. medmix dijo que GEKA aseguró uno de sus proyectos individuales más grandes, y se espera que genere ingresos significativos en 2026-2027. Ambos proyectos enfatizan la automatización y la producción sostenible.
medmix (MDMXF)가 Beauty 부문 강화를 위한 두 곳의 설비 확장을 발표했습니다: 중국 Guangdong Qiaoyi 자회사를 위한 새로운 4,000 m² 생산시설과 상파울루주 Cotia에 위치한 GEKA do Brasil의 대규모 확장.
Qiaoyi 공장은 전용 주사 성형 작업장, AI 자동화 및 3D 창고를 추가하여 아시아용 화장품 포장 생산량을 확대합니다. GEKA 확장은 브라질 지사를 두 배 이상으로 확장하고, 창고를 내부 운영으로 전환하며 용량을 25% 증가시켰습니다. medmix는 GEKA가 회사의 가장 큰 단일 프로젝트 중 하나를 확보했다고 밝히고 있으며, 2026–2027년에 상당한 매출을 창출할 것으로 기대됩니다. 두 프로젝트 모두 자동화와 지속 가능한 생산에 중점을 두고 있습니다.
medmix (MDMXF) a annoncé deux extensions d’installations pour renforcer son segment Beauté : un nouveau site de production de 4 000 m² pour la filiale Guangdong Qiaoyi en Chine et une importante extension de GEKA do Brasil à Cotia, São Paulo.
L’usine Qiaoyi ajoute un atelier d’injection dédié, une automatisation par IA et un entrepôt 3D pour augmenter la production d’emballages cosmétiques pour l’Asie. L’extension de GEKA a plus que doublé le site brésilien, externalisé l’entreposage et augmenté la capacité de 25%. medmix indique que GEKA a décroché l’un de ses plus grands projets uniques, qui devrait générer des revenus significatifs en 2026–2027. Les deux projets mettent l’accent sur l’automatisation et une production durable.
medmix (MDMXF) kündigte zwei Standortexpansionen an, um seine Beauty-Sparte zu stärken: einen neuen 4.000 m² Produktionsstandort für die Tochter Guangdong Qiaoyi in China und eine umfangreiche Expansion von GEKA do Brasil in Cotia, São Paulo.
Die Qiaoyi-Anlage ergänzt eine dedizierte Spritzgießwerkstatt, KI-Automatisierung und ein 3D-Lager, um die Kosmetikverpackungsproduktion für Asien zu skalieren. Die GEKA-Erweiterung hat den brasilianischen Standort mehr als verdoppelt, insourcing von Lagerhaltung und eine Kapazitätserhöhung um 25% ermöglicht. medmix sagte, GEKA habe eines der größten Einzelprojekte seines Unternehmens gesichert, das voraussichtlich signifikante Umsätze in 2026–2027 generieren werde. Beide Projekte legen den Schwerpunkt auf Automatisierung und nachhaltige Produktion.
medmix (MDMXF) أعلنت عن توسعين في المنشآت لتعزيز قسم الجمال لديها: موقع إنتاج جديد بمساحة 4,000 م² للمجموعة Guangdong Qiaoyi في الصين وتوسعاً كبيراً في GEKA do Brasil في كوتيا، ساو باولو.
يضيف مصنع Qiaoyi ورشة حقن مخصصة، وأتمتة بالذكاء الاصطناعي ومستودع ثلاثي الأبعاد لتوسيع OUTPUT التعبئة والتغليف لمستحضرات التجميل في آسيا. توسعة GEKA ضاعفت الموقع البرازيلي، وأدخلت التخزين داخلياً و زادت القدرة بنسبة 25%. قالت medmix إن GEKA أمنت أحد أكبر مشاريعها الفردية، ومن المتوقع أن تحقق عوائد كبيرة في 2026–2027. كلا المشروعين يركّزان على الأتمتة والإنتاج المستدام.
medmix (MDMXF)宣布了两项设施扩张，以加强其美妆业务板块：在中国为子公司 Guangdong Qiaoyi 新建一个占地 4,000 m² 的生产基地，以及在圣保罗州 Cotia 的 GEKA do Brasil 进行大规模扩张。
Qiaoyi 工厂新增专用注塑车间、AI 自动化以及一个 3D 仓库，以扩大面向亚洲的化妆品包装产出。GEKA 的扩张使巴西工厂规模翻倍以上，内部化仓储并 容量提升 25%。medmix 表示 GEKA 获得其最大的单笔项目之一，预计在 2026–2027 年 实现显著收入。两项工程都强调自动化与可持续生产。
- New 4,000 m² Qiaoyi production facility in China
- GEKA Brazil facility capacity +25%
- GEKA secured one of the company's largest single projects delivering revenues in 2026–2027
- Advanced automation: AI-powered systems and 3D warehouse at Qiaoyi
- Insourced warehousing after more-than-2x expansion of Brazilian site
- None.
Baar, Switzerland--(Newsfile Corp. - October 8, 2025) -
medmix AG
Neuhofstrasse 20
CH-6430 Baar
communications@medmix.com
www.medmix.swiss
MEDIA RELEASE
medmix Wins One of the Largest New Beauty Businesses in Company History and Strengthens Position in Key Global Beauty Markets with Facility Extensions
medmix Group strengthens its position in key global beauty markets through strategic facility expansions, opening a second state-of-the-art production facility for its subsidiary Guangdong Qiaoyi Plastic Co. Ltd. (Qiaoyi) in China and completing a major expansion of its GEKA operations in Brazil. In addition to these strategic initiatives, GEKA has recently achieved strong progress in securing new projects, among them one of the largest single projects and new business deals in the company’s history. This project will deliver significant revenues in 2026 and 2027.
The new 4,000-square-meter Qiaoyi facility in China includes a dedicated injection workshop with large-scale machinery, a three-dimensional warehouse system, and AI-powered automation. With these advanced capabilities, the plant can significantly ramp up the production of cosmetic packaging such as lip gloss, lipstick and compact cases, serving the rapidly growing Asian beauty market.
Complementing this growth in Asia, GEKA do Brasil has officially opened its expanded facility in Cotia, São Paulo, marking both 10 years of local production in Latin America and the 100th anniversary of the GEKA brand. GEKA has more than doubled its Brazilian facility, insourcing warehousing and allowing both finished and semi-finished products to be stored on-site. The expansion increased capacity by
"Our global footprint allows us to meet our customers’ needs for global, synchronized product launches. Since acquiring Qiaoyi in 2023, we have been impressed by their innovation capabilities and deep understanding of the Asian beauty market," said René Willi, CEO of medmix Group. "Combined with our Brazilian expansion, these developments represent significant milestones in our Beauty growth strategy as we strengthen our presence in key beauty markets worldwide while meeting the evolving needs of our customers."
Both expansions emphasize automation and sustainable production processes, reflecting medmix' dedication to operational excellence and environmental responsibility while serving dynamic global markets.
-Ends-
About medmix
medmix is a global leader in high-precision delivery devices, with leading positions in healthcare, consumer and industrial end-markets. Our customers benefit from our dedication to innovation and technological advancement that has resulted in over 900 active patents. Our 14 production sites worldwide together with our highly motivated and experienced team of nearly 2’700 employees are at service of our customers with uncompromising quality, proximity and agility. medmix is headquartered in Baar, Switzerland. Our shares are traded on the SIX Swiss Exchange (SIX: MEDX). www.medmix.swiss
Inquiries:
Media Relations: communications@medmix.com
Investor Relations: investorrelations@medmix.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/269620
FAQ
What did medmix (MDMXF) announce on October 8, 2025 about its Beauty operations?
How much did GEKA do Brasil increase capacity after the Cotia expansion?
Will medmix (MDMXF) see revenue from the new GEKA project, and when?
What manufacturing upgrades does the new Qiaoyi facility include?
How do these expansions affect medmix's global Beauty footprint?
Does medmix mention sustainability or operational goals for these facilities?
